Showing results (431-440 of 986) with videos related to

Sort By:
Pageof 99
Circulation. Heart Failure|January 25, 2023
Hemodynamic Profiling and Prognosis in Cardiac AmyloidosisPieter Martens, Sanjeeb Bhattacharya, Joshua Longinow, et al.
Journal of the American Heart Association|November 1, 2018
Body Mass Index, Natriuretic Peptides, and Risk of Adverse Outcomes in Patients With Heart Failure and Preserved Ejection Fraction: Analysis From the TOPCAT TrialAmbarish Pandey, Jarett D Berry, Mark H Drazner, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1988
Circadian rhythm of adrenergic regulation of adrenocorticotropin and cortisol secretion in manM R Naylor, K R Krishnan, A N Manepalli, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 25, 2011
Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary eraMaria Patarroyo, Cesar Simbaqueba, Kevin Shrestha, et al.
The American Journal of Cardiology|August 18, 2020
Digoxin Use in Cardiac AmyloidosisJoseph P Donnelly, Brett W Sperry, Andrej Gabrovsek, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 25, 2018
Relative quantification of beta-adrenergic receptor in peripheral blood cells using flow cytometryDidem Saygin, Nicholas Wanner, Jonathan A Rose, et al.
Journal of Cardiac Failure|August 25, 2009
Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomesSlava Epelman, Kevin Shrestha, Richard W Troughton, et al.
Circulation. Heart Failure|February 24, 2010
Right ventricular response to intensive medical therapy in advanced decompensated heart failureDavid Verhaert, Wilfried Mullens, Allen Borowski, et al.
Journal of Cardiac Failure|September 24, 2013
Increasing serum soluble angiotensin-converting enzyme 2 activity after intensive medical therapy is associated with better prognosis in acute decompensated heart failureZhili Shao, Kevin Shrestha, Allen G Borowski, et al.
Clinical Biochemistry|February 25, 2017
Circulating intestinal fatty acid-binding protein (I-FABP) levels in acute decompensated heart failureTakeshi Kitai, Yong-Hyun Kim, Kathryn Kiefer, et al.
Pageof 99